新希望(000876.SZ):擬收購天津精武種豬等5家公司100%股權
格隆匯 9 月 17日丨新希望(000876.SZ)公佈,公司第八屆董事會第二十二次會議決議,審議通過了“關於收購天津市精武種豬有限公司等5家公司100%股權的議案”。
根據公司生豬產業發展戰略,公司擬收購天津市精武種豬有限公司、天津市清楊德盛種豬有限公司、天津市聖西聯華畜禽養殖有限公司、天津市國泰養殖有限公司、天津市綠地源有機肥有限公司5家公司(以下合稱“標的公司”)100%股權,標的公司擁有設計存欄規模為父母代6000頭、配套保育育肥63000頭的豬場全套合規手續以及土建、鋼構、設備、道路等在建工程、固定資產和流動資產。標的公司100%股權收購價格為人民幣12200萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.